SCHEDULE: Scilex Holding Company: SCLX Stock Acquisition JV LLC Files Schedule 13D Amendment

SCLX Stock Acquisition JV LLC has filed an amendment to its Schedule 13D, reporting changes in its beneficial ownership of Scilex Holding Company common stock and Series A Preferred Stock.

Summary

• SCLX Stock Acquisition JV LLC, a reporting person, has filed Amendment No. 6 to its Schedule 13D concerning Scilex Holding Company's common stock.
• The filing reflects a reverse stock split of Scilex Holding Company's common stock at a 1-for-35 ratio, effective April 15, 2025.
• On July 3, 2026, SCLX Stock Acquisition JV LLC transferred 500,000 shares of Scilex Holding Company common stock to Quantum Scan Holdings, Inc. (Q Scan) in exchange for Q Scan's common stock.
• The transfer price of these shares is based on Scilex Holding Company's closing stock price on the Nasdaq Capital Market on the trading day before the transfer.
• As of the filing date, SCLX Stock Acquisition JV LLC beneficially owns 30,029,378 shares, representing 11.4% of the class of securities.
• This ownership includes 958,263 shares of common stock, 14,018 shares issuable upon warrant exercise within 60 days, and 29,057,097 shares of Series A Preferred Stock.
• The Series A Preferred Stock is entitled to vote with common stockholders on an as-converted basis, contributing 848,106 votes as of the filing date.
• The aggregate voting power, including warrants and Series A Preferred Stock, is 19.3%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on a change in beneficial ownership and a share transfer transaction rather than announcing new financial results or strategic initiatives.

Positives

• The reporting person maintains a significant beneficial ownership stake of 11.4% in Scilex Holding Company.
• The Series A Preferred Stock provides substantial voting power (848,106 votes), contributing to a total voting power of 19.3% when combined with common stock and exercisable warrants.

Negatives

• The transfer of 500,000 shares to Q Scan represents a reduction in the direct common stock holdings of SCLX Stock Acquisition JV LLC.
• The filing indicates a reverse stock split, which can sometimes be perceived negatively by the market as a sign of a company struggling to maintain its stock price.

Risks

• The price at which the 500,000 shares were transferred to Q Scan is dependent on the closing price of Scilex Holding Company's common stock, introducing price volatility risk for the transaction value.
• The significant proportion of Series A Preferred Stock held by the reporting person could lead to complex voting dynamics and potential conflicts of interest.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company regarding future financial performance or strategic direction. The primary forward-looking aspect relates to the potential exercise of warrants within 60 days of the filing date.

Management Comments

• The reporting person's aggregate voting power, including shares of Series A Preferred Stock and assuming the exercise of all warrants, is 19.3%.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are crucial for tracking significant ownership changes and potential shifts in control or influence within publicly traded companies. This amendment details a specific transaction involving the transfer of shares and highlights the complex capital structure of Scilex Holding Company, including preferred stock with voting rights.

Related Party Transactions

• Transfer of 500,000 shares of Common Stock by SCLX Stock Acquisition JV LLC to Quantum Scan Holdings, Inc. in exchange for shares of Q Scan's common stock.

Stakeholder Impact

• Shareholders: The reverse stock split may impact per-share value and perception. The share transfer by a significant holder could influence market sentiment and trading dynamics.
• Creditors: No direct impact mentioned.
• Employees: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Customers: No direct impact mentioned.

Next Steps

• The transfer of 500,000 shares of Common Stock to Q Scan is to be completed based on the Letter Agreement.
• Potential exercise of 14,018 warrants within 60 days of the filing date.

Key Dates

Keywords

Schedule 13D, Scilex Holding Company, SCLX Stock Acquisition JV LLC, Beneficial Ownership, Common Stock, Series A Preferred Stock, Quantum Scan Holdings, Reverse Stock Split, SEC Filing, Warrants